NGM Biopharmaceuticals: Q4 Earnings Snapshot
By AP News
Published - Mar 11, 2024, 04:30 PM ET
Last Updated - Mar 11, 2024, 04:30 PM EDT
SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — NGM Biopharmaceuticals Inc. (NGM) on Monday reported a loss of $27.7 million in its fourth quarter.
The South San Francisco, California-based company said it had a loss of 33 cents per share.
The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 37 cents per share.
The biotechnology company posted revenue of $165,000 in the period.
